HSPA1A and triple-negative breast carcinoma: HSPA1A knockdown by siRNA in triple negative breast cancer-derived MDA-MB-231 cells abrogated their resistance to radiation exposure [153]; this suggests a possibility of targeting the HSP70 expression to improve the action of radiotherapy against triple negative breast cancer.